Characterization of KRAS-driven survival signaling networks via phosphoproteomics in lung cancer.

被引：0
|
作者：
Kim, Jae-Young [1 ]
Welsh, Eric A. [1 ]
Fang, Bin [1 ]
Li, Jiannong [1 ]
Eschrich, Steven A. [1 ]
Koomen, John [1 ]
Haura, Eric B. [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-A61
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A61
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Therapeutic Approaches in KRAS-Driven Non-Small Cell Lung Cancer
    McCoach, C. E.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S2 - S2
  • [22] AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer
    Daniela Welcker
    Manaswita Jain
    Safiya Khurshid
    Mladen Jokić
    Martin Höhne
    Anna Schmitt
    Peter Frommolt
    Carien M. Niessen
    Judith Spiro
    Thorsten Persigehl
    Maike Wittersheim
    Reinhard Büttner
    Maurizio Fanciulli
    Bernhard Schermer
    Hans Christian Reinhardt
    Thomas Benzing
    Katja Höpker
    Oncogene, 2018, 37 : 1503 - 1518
  • [23] RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas
    Konstantinidou, Georgia
    Ramadori, Giorgio
    Torti, Francesca
    Kangasniemi, Kim
    Ramirez, Rachel E.
    Cai, Yiran
    Behrens, Carmen
    Dellinger, Michael T.
    Brekken, Rolf A.
    Wistuba, Ignacio I.
    Heguy, Adriana
    Teruya-Feldstein, Julie
    Scaglioni, Pier Paolo
    CANCER DISCOVERY, 2013, 3 (04) : 444 - 457
  • [24] Cancer vaccines: Targeting KRAS-driven cancers
    Zhang, Ying
    Ma, Jin-An
    Zhang, Hai-Xia
    Jiang, Yu-Na
    Luo, Wen-Hao
    EXPERT REVIEW OF VACCINES, 2020, 19 (02) : 163 - 173
  • [25] Leukemia inhibitory factor promotes tumor progression in KRAS-driven lung cancer
    Hanafi, Imene Boukhalfa
    Miller-Phillips, Lisa
    Zakraoui, Ons
    Marini, Kieren D.
    Umetsu, Sarah
    Wang, Man-Tzu
    Collisson, Eric A.
    CANCER RESEARCH, 2024, 84 (06)
  • [26] Metabolic vulnerability of KRAS-driven cancer cells
    Foster, David A.
    MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (03):
  • [27] Identification of novel combinatorial synthetic lethal vulnerabilities in KRAS-driven lung cancer
    Kostyrko, Kaja
    Kelly, Marcus R.
    Han, Kyuho
    Jeng, Edwin E.
    Morgens, David W.
    Bassik, Michael C.
    Jackson, Peter K.
    Sweet-Cordero, Alejandro
    CANCER RESEARCH, 2018, 78 (13)
  • [28] The ERBB network facilitates KRas-driven lung tumorigenesis
    Kruspig, Bjorn
    Monteverde, Tiziana
    Neidler, Sarah
    Hock, Andreas
    Kerr, Emma
    Nixon, Colin
    Clark, William
    Hedley, Ann
    Dick, Craig
    Vousden, Karen
    Martins, Carla
    Murphy, Daniel
    CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (08) : 508 - 508
  • [29] Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
    Pan, Jing
    Zhang, Qi
    Sei, Shizuko
    Shoemaker, Robert H.
    Lubet, Ronald A.
    Wang, Yian
    You, Ming
    ONCOTARGET, 2017, 8 (47) : 82689 - 82699
  • [30] The ERBB network facilitates KRAS-driven lung tumorigenesis
    Kruspig, Bjorn
    Monteverde, Tiziana
    Neidler, Sarah
    Hock, Andreas
    Kerr, Emma
    Nixon, Colin
    Clark, William
    Hedley, Ann
    Laing, Sarah
    Coffelt, Seth B.
    Le Quesne, John
    Dick, Craig
    Vousden, Karen
    Martins, Carla P.
    Murphy, Daniel J.
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (446)
12345